| 000 | 01174 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517120149.0 | ||
| 264 | 0 | _c20170227 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a1744-764X | ||
| 024 | 7 |
_a10.1080/14740338.2016.1237500 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAmro, Farah H | |
| 245 | 0 | 0 |
_aTreatment options for hypertension in pregnancy and puerperium. _h[electronic resource] |
| 260 |
_bExpert opinion on drug safety _cDec 2016 |
||
| 300 |
_a1635-1642 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFetus _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pregnancy-Induced _xdrug therapy |
| 650 | 0 | 4 |
_aPlacenta _xblood supply |
| 650 | 0 | 4 | _aPostpartum Period |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aPregnancy |
| 700 | 1 | _aMoussa, Hind N | |
| 700 | 1 | _aAshimi, Olaide A | |
| 700 | 1 | _aSibai, Baha M | |
| 773 | 0 |
_tExpert opinion on drug safety _gvol. 15 _gno. 12 _gp. 1635-1642 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14740338.2016.1237500 _zAvailable from publisher's website |
| 999 |
_c26472077 _d26472077 |
||